Medlab Clinical (Medlab Clinical) Total Assets : $0.25 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical Total Assets?

Medlab Clinical's Total Assets for the quarter that ended in Dec. 2023 was $0.25 Mil.

During the past 12 months, Medlab Clinical's average Total Assets Growth Rate was -98.10% per year. During the past 3 years, the average Total Assets Growth Rate was -30.60% per year. During the past 5 years, the average Total Assets Growth Rate was -7.70% per year.

During the past 8 years, Medlab Clinical's highest 3-Year average Total Assets Growth Rate was 52.60%. The lowest was -30.60%. And the median was 21.80%.

Total Assets is connected with ROA %. Medlab Clinical's annualized ROA % for the quarter that ended in Dec. 2023 was -224.56%. Total Assets is also linked to Revenue through Asset Turnover. Medlab Clinical's Asset Turnover for the quarter that ended in Dec. 2023 was 0.03.

Medlab Clinical Total Assets Historical Data

The historical data trend for Medlab Clinical's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Total Assets Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

14.03

12.28

15.78

7.99

2.11

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial												11.52	7.99	4.38	2.11	0.25

Medlab Clinical Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Medlab Clinical's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	0.859	+	1.251
	=	2.11

Medlab Clinical's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-0.469	+	0.722
	=	0.25

Medlab Clinical (OTCPK:MDBBF) Total Assets Explanation

Total Assets is connected with ROA %.

Medlab Clinical's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-2.652	/	( (2.11	+	0.252)	/ 2 )
	=	-2.652	/	1.181
	=	-224.56 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Medlab Clinical's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.032	/	( (2.11	+	0.252)	/ 2 )
=	0.032	/	1.181
=	0.03

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Medlab Clinical Total Assets Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.